regeneron - Search News

News

Fujifilm, Regeneron

Reuters on MSN · 1d

Regeneron to invest over $3 billion to boost US manufacturing

Regeneron Pharmaceuticals said on Tuesday it has signed a deal worth more than $3 billion with contract drug developer Fujifilm Diosynth, potentially doubling its U.S. manufacturing capacity and bringing its total investments in the country to over $7 billion.

Bloomberg on MSN · 2d

Regeneron Inks $3 Billion Fujifilm Deal to Bolster US Drugmaking

Regeneron Pharmaceuticals Inc. agreed to pay Fujifilm Diosynth Biotechnologies more than $3 billion over the next decade to help manufacture its medicines in the US, as the threat of tariffs looms over the nation’s drug supply.

The News & Observer on MSN · 18h

Fujifilm lands another drugmaker to new Holly Springs plant with $3 billion deal

On Tuesday, Fujifilm Diosynth announced a 10-year agreement worth more than $3 billion to make medicines for the New York drugmaker Regeneron in the Triangle. Regeneron is the facility’s third major customer, following earlier agreements with Johnson & Johnson and TG Therapeutics.

Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation

With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics ...

1d

Regeneron price target lowered to $975 from $1,004 at Truist

Truist lowered the firm’s price target on Regeneron (REGN) to $975 from $1,004 and keeps a Buy rating on the shares. The firm notes Regeneron ...

Fierce Pharma3d

FDA rejection of extended dosing interval is another piece of bad news for Regeneron’s Eylea HD

The FDA has sent Regeneron a complete response letter, rejecting its bid to stretch the administration of high-dose Eylea ...

Roche, Regeneron Announce Combined $56B Expansions As Tariffs Loom

Swiss drugmaker Roche will spend $50B to expand its U.S. manufacturing, while New York-based Regeneron will spend more than ...

Ophthalmology Times2d

Regeneron announces FDA issues CRL for aflibercept 8 mg (Eylea HD) sBLA

The FDA did not agree with a supplemental Biologics License Application for the addition of extended dosing intervals of up ...

1d

Analysts Are Bullish on These Healthcare Stocks: Regeneron (REGN), Intuitive Surgical (ISRG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN – Research Report) and Intuitive ...

5don MSN

Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition

The U.S. Food and Drug Administration approved the use of Sanofi and Regeneron's blockbuster drug Dupixent for patients with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results